Familial hypertrophic cardiomyopathy (FHC) is a disease of the sarcomere where the resulting hypertrophy is associated with pump failure of arrythymias. The sarcomeric alterations involve point mutations in the myosin molecule or in other proteins (thin filament and C protein). In this study we use genetically altered (heterozygous and homozygous) mice that mimic some of the key point mutations found in FHC (myosin: R403Q, V606M, D778G; G741R, R719Q, G584R; alpha-tropomyosin: D175N; and troponin- T:I79N). Permeabilized papillary muscle strips (skinned fibers) will be studied mechanistically to provide a detailed functional characterization of mutant contractile proteins within the spatial constraints of the structured fibers. The mechanical analysis will in turn be compared with correlative in vivo ventricular function studies and single molecule mechanics. From our studies we expect to be able to characterize the mechanical alterations found in the disease in terms of power output, force absorbing and force producing elements, velocity, cross-bridge kinetic parameters and calcium sensitivity. From this analysis we anticipate being able to define the key elements that lead to the pump failure and thus the potential targets for therapeutic intervention. In addition, the point mutations in specific regions of the myosin molecule as well as in the thin filament proteins (tropomyosin and troponin) will allow us to develop new insights into the contribution of small structural changes (point mutations) to the functional alterations.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL059408-02
Application #
6302502
Study Section
Project Start
2000-02-01
Project End
2001-01-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
2
Fiscal Year
2000
Total Cost
$253,000
Indirect Cost
Name
University of Vermont & St Agric College
Department
Type
DUNS #
066811191
City
Burlington
State
VT
Country
United States
Zip Code
05405
Singh, Sonia R; Robbins, Jeffrey (2018) Desmin and Cardiac Disease: An Unfolding Story. Circ Res 122:1324-1326
Lin, Brian Leei; Li, Amy; Mun, Ji Young et al. (2018) Skeletal myosin binding protein-C isoforms regulate thin filament activity in a Ca2+-dependent manner. Sci Rep 8:2604
Kensler, Robert W; Craig, Roger; Moss, Richard L (2017) Phosphorylation of cardiac myosin binding protein C releases myosin heads from the surface of cardiac thick filaments. Proc Natl Acad Sci U S A 114:E1355-E1364
McLendon, Patrick M; Davis, Gregory; Gulick, James et al. (2017) An Unbiased High-Throughput Screen to Identify Novel Effectors That Impact on Cardiomyocyte Aggregate Levels. Circ Res 121:604-616
Bhuiyan, Md Shenuarin; McLendon, Patrick; James, Jeanne et al. (2016) In vivo definition of cardiac myosin-binding protein C's critical interactions with myosin. Pflugers Arch 468:1685-95
Gupta, Manish K; McLendon, Patrick M; Gulick, James et al. (2016) UBC9-Mediated Sumoylation Favorably Impacts Cardiac Function in Compromised Hearts. Circ Res 118:1894-905
Warshaw, David M (2016) HEART DISEASE. Throttling back the heart's molecular motor. Science 351:556-7
James, Jeanne; Robbins, Jeffrey (2016) Healing a Heart Through Genetic Intervention. Circ Res 118:920-2
Mun, Ji Young; Kensler, Robert W; Harris, Samantha P et al. (2016) The cMyBP-C HCM variant L348P enhances thin filament activation through an increased shift in tropomyosin position. J Mol Cell Cardiol 91:141-7
Previs, Michael J; Mun, Ji Young; Michalek, Arthur J et al. (2016) Phosphorylation and calcium antagonistically tune myosin-binding protein C's structure and function. Proc Natl Acad Sci U S A 113:3239-44

Showing the most recent 10 out of 168 publications